Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.775 USD | +1.21% | +1.34% | +603.91% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+603.91% | 204M | |
+10.15% | 114B | |
+12.72% | 107B | |
-5.50% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.39% | 17.51B | |
-39.36% | 17.17B | |
+6.60% | 14.14B | |
+34.81% | 12.2B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- SVB Securities Downgrades Elevation Oncology to Market Perform From Outperform, Adjusts Price Target to $2 From $11